A Phase 2/3, multicenter, randomized, open-label study evaluating the efficacy and safety of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in frailer transplant-ineligible patients with newly diagnosed multiple myeloma
Por:
Manier, S, Puig, N, Leleu, X, Oriol, A, Hulin, C, Garcia-Sanz, R, Corre, J, San-Miguel, J, Facon, T, Lee, H, Forsberg, P, Chatterjee, K, Svensson, A, Talati, C, He, SY, Doerr, T, Arriola, E, Dillon, M, Lin, JNF, Nguyen, L, Wang, F and Mateos, MV
Publicada:
1 dic 2025
Ahead of Print:
1 dic 2025
Resumen:
Filiaciones:
Manier, S:
Lille Univ, Ctr Hosp Univ Lille, Dept Hematol, Lille, France
Puig, N:
Hosp Univ Salamanca, Ctr Invest Biomed Red Canc, Consejo Super Invest Cienticas, IBSAL,Inst Biol Mol & Celular Canc,Hematol Dept, Salamanca, Spain
Leleu, X:
CHU, Serv Hematol & Therapie Cellulaire, Poitiers, France
CIC Inserm 1402, Poitiers, France
:
Hosp Germans Trias i Pujol, Inst Catala Oncol, Inst Josep Carreras, Barcelona, Spain
Hulin, C:
Hop Haut Leveque, Ctr Hosp Univ CHU Bordeaux, Serv Hematol, Pessac, France
Garcia-Sanz, R:
Hosp Gen Univ Gregorio Maranon, Hematol Dept, CIBERONC IBSAL, Madrid, Spain
Corre, J:
Univ Canc Ctr Toulouse, Inst Natl Sante & Rech Med, Unite Genom Myelome, Toulouse, France
San-Miguel, J:
Canc Ctr Clin Univ Navarra, Inst Invest Sanitaria Navarra, Ctr Invest Med Aplicada, CIBER-ONC CB16-12-00369 & CB16-12-00489, Pamplona, Spain
Facon, T:
Univ Lille, Paris, France
French Acad Med, Dept Haematol, Paris, France
Lee, H:
Sarah Cannon Res Inst, Nashville, TN USA
Chatterjee, K:
AbbVie Inc, N Chicago, IL USA
Svensson, A:
AbbVie Inc, N Chicago, IL USA
Talati, C:
AbbVie Inc, N Chicago, IL USA
He, SY:
AbbVie Inc, N Chicago, IL USA
Doerr, T:
AbbVie Inc, N Chicago, IL USA
Arriola, E:
AbbVie Inc, N Chicago, IL USA
Dillon, M:
AbbVie Inc, N Chicago, IL USA
Lin, JNF:
AbbVie Inc, N Chicago, IL USA
Nguyen, L:
AbbVie Inc, N Chicago, IL USA
Wang, F:
AbbVie Inc, N Chicago, IL USA
Mateos, MV:
CHU, Serv Hematol & Therapie Cellulaire, Poitiers, France
CIC Inserm 1402, Poitiers, France
Hosp Univ Salamanca, IBSAL, CIC, Ciberonc, Salamanca, Spain
|